Net loss of Genomic Valley Biotech reported to Rs 0.04 crore in the quarter ended March 2024 as against net profit of Rs 0.98 crore during the previous quarter ended March 2023. There were no Sales reported in the quarter ended March 2024 as against Rs 1.00 crore during the previous quarter ended March 2023.
For the full year,net profit declined 96.92% to Rs 0.02 crore in the year ended March 2024 as against Rs 0.65 crore during the previous year ended March 2023. Sales declined 93.75% to Rs 0.17 crore in the year ended March 2024 as against Rs 2.72 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 0 | 1.00 | -100 | 0.17 | 2.72 | -94 |
| OPM % | 0 | 93.00 | - | 11.76 | 32.35 | - |
| PBDT | -0.04 | 0.94 | PL | 0.02 | 0.92 | -98 |
| PBT | -0.04 | 0.95 | PL | 0.02 | 0.91 | -98 |
| NP | -0.04 | 0.98 | PL | 0.02 | 0.65 | -97 |